Huntingdon Life Sciences Announces Expansion Of Pre-Clinical Pharmaceutical Inhalation Facility In U.S. 
10/19/2005 5:13:12 PM

EAST MILLSTONE, N.J.--(BUSINESS WIRE)--April 4, 2005--Huntingdon Life Sciences, a leading provider of pre-clinical research services in support of pharmaceutical product development, today announces the expansion of its pharmaceutical inhalation safety testing facility at its location in East Millstone, New Jersey, near Princeton. This expansion doubles Huntingdon's capacity at its East Millstone location, and will include a number of state-of-the art enhancements designed to exceed the increasingly rigorous requirements demanded by the pharmaceutical industry to ensure that cross-contamination of exposure groups does not compromise their critical respiratory safety assessment programs.